{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:22:14Z","timestamp":1787030534605,"version":"build-2736575974"},"reference-count":36,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed Rep"],"DOI":"10.3892\/br.2026.2174","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:09:18Z","timestamp":1782475758000},"page":"1-5","source":"Crossref","is-referenced-by-count":1,"title":["Carbamazepine\u2011induced Stevens\u2011Johnson syndrome in Chinese with negative HLA\u2011A*3101 and HLA\u2011B*1502 genes: A case report"],"prefix":"10.3892","volume":"25","author":[{"given":"Zidan","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Wufeng Tujia Autonomous County People's Hospital Yichang, Hubei 443413, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimin","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Wufeng Tujia Autonomous County People's Hospital Yichang, Hubei 443413, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"key20260715102426_b1-BR-25-2-02174","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.jid.2017.01.031","article-title":"The epidemiology of stevens-johnson syndrome and toxic epidermal necrolysis in the UK","volume":"137","author":"Frey","year":"2017","journal-title":"J Invest Dermatol"},{"key":"key20260715102426_b2-BR-25-2-02174","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jdermsci.2020.09.009","article-title":"The nationwide epidemiological survey of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan, 2016-2018","volume":"100","author":"Sunaga","year":"2020","journal-title":"J Dermatol Sci"},{"key":"key20260715102426_b3-BR-25-2-02174","doi-asserted-by":"publisher","first-page":"382","DOI":"10.2174\/0115748863328893241018101435","article-title":"Carbamazepine-induced Stevens-Johnson syndrome: A case report with review of the literature","volume":"20","author":"Subramanian","year":"2025","journal-title":"Curr Drug Saf"},{"issue":"bcr2016214926","key":"key20260715102426_b4-BR-25-2-02174","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-214926","article-title":"Carbamazepine induced Stevens-Johnson syndrome","volume":"2016","author":"Khoo","year":"2016","journal-title":"BMJ Case Rep"},{"key":"key20260715102426_b5-BR-25-2-02174","doi-asserted-by":"publisher","first-page":"755","DOI":"10.19723\/j.issn.1671-167X.2023.04.030","article-title":"Carbamazepine induced Stevens-Johnson syndrome in Han Chinese with positive HLA-A * 3101 gene: A case report","volume":"55","author":"Xu","year":"2023","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban"},{"issue":"1213889","key":"key20260715102426_b6-BR-25-2-02174","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1213889","article-title":"Updates in SJS\/TEN: Collaboration, innovation, and community","volume":"10","author":"Marks","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"652091","key":"key20260715102426_b7-BR-25-2-02174","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.652091","article-title":"Genetics of severe cutaneous adverse reactions","volume":"8","author":"Yang","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"832048","key":"key20260715102426_b8-BR-25-2-02174","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.832048","article-title":"Drug-induced severe cutaneous adverse reactions: Insights into clinical presentation, immunopathogenesis, diagnostic methods, treatment, and pharmacogenomics","volume":"13","author":"Tempark","year":"2022","journal-title":"Front Pharmacol"},{"key":"key20260715102426_b9-BR-25-2-02174","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/cpt.1944","article-title":"Global frequencies of clinically important HLA alleles and their implications for the cost-effectiveness of preemptive pharmacogenetic testing","volume":"109","author":"Zhou","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"key20260715102426_b10-BR-25-2-02174","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/cpt.1004","article-title":"Clinical pharmacogenetics implementation consortium guideline for HLA genotype and use of carbamazepine and oxcarbazepine: 2017 update","volume":"103","author":"Phillips","year":"2018","journal-title":"Clin Pharmacol Ther"},{"issue":"588063","key":"key20260715102426_b11-BR-25-2-02174","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.588063","article-title":"Current pharmacogenetic perspective on Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"12","author":"Cheng","year":"2021","journal-title":"Front Pharmacol"},{"issue":"883121","key":"key20260715102426_b12-BR-25-2-02174","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.883121","article-title":"Scoring assessments in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"9","author":"Dobry","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"key20260715102426_b13-BR-25-2-02174","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ajo.2019.01.028","article-title":"Multistep grading system for evaluation of chronic ocular sequelae in patients with Stevens-Johnson syndrome","volume":"203","author":"Sharma","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"key20260715102426_b14-BR-25-2-02174","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1097\/CM9.0000000000003250","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: Updates in pathophysiology and management","volume":"137","author":"Hasegawa","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"key20260715102426_b15-BR-25-2-02174","author":"Oakley"},{"key":"key20260715102426_b16-BR-25-2-02174","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-0716-3874-3_1","article-title":"HLA genes: A hallmark of functional genetic variation and complex evolution","volume":"2809","author":"Lenz","year":"2024","journal-title":"Methods Mol Biol"},{"key":"key20260715102426_b17-BR-25-2-02174","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00251-017-1007-5","article-title":"The role of HLA genes in pharmacogenomics: Unravelling HLA associated adverse drug reactions","volume":"69","author":"Illing","year":"2017","journal-title":"Immunogenetics"},{"key":"key20260715102426_b18-BR-25-2-02174","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1111\/cts.13291","article-title":"Associations of HLA genetic variants with carbamazepine-induced cutaneous adverse drug reactions: An updated meta-analysis","volume":"15","author":"Biswas","year":"2022","journal-title":"Clin Transl Sci"},{"key":"key20260715102426_b19-BR-25-2-02174","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s12325-017-0530-y","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: A concise review with a comprehensive summary of therapeutic interventions emphasizing supportive measures","volume":"34","author":"Schneider","year":"2017","journal-title":"Adv Ther"},{"key":"key20260715102426_b20-BR-25-2-02174","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1093\/hmg\/ddq537","article-title":"Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population","volume":"20","author":"Ozeki","year":"2011","journal-title":"Hum Mol Genet"},{"key":"key20260715102426_b21-BR-25-2-02174","author":"Hasegawa"},{"issue":"CD013130","key":"key20260715102426_b22-BR-25-2-02174","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013130.pub2","article-title":"Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS\/TEN overlap syndrome","volume":"3","author":"Jacobsen","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"key20260715102426_b23-BR-25-2-02174","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s40257-019-00443-9","article-title":"Association of early systemic corticosteroid therapy with mortality in patients with Stevens-Johnson syndrome or toxic epidermal necrolysis: A retrospective cohort study using a nationwide claims database","volume":"20","author":"Morita","year":"2019","journal-title":"Am J Clin Dermatol"},{"key":"key20260715102426_b24-BR-25-2-02174","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1001\/jamadermatol.2016.5668","article-title":"Systemic immunomodulating therapies for Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review and meta-analysis","volume":"153","author":"Zimmermann","year":"2017","journal-title":"JAMA Dermatol"},{"key":"key20260715102426_b25-BR-25-2-02174","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/ijd.12423","article-title":"Intravenous immunoglobulin in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: A meta-analysis with meta-regression of observational studies","volume":"54","author":"Barron","year":"2015","journal-title":"Int J Dermatol"},{"key":"key20260715102426_b26-BR-25-2-02174","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.jaad.2020.08.122","article-title":"Treating toxic epidermal necrolysis with systemic immunomodulating therapies: A systematic review and network meta-analysis","volume":"84","author":"Tsai","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"750173","key":"key20260715102426_b27-BR-25-2-02174","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.750173","article-title":"Intravenous immunoglobulin combined with corticosteroids for the treatment of Stevens-Johnson syndrome\/toxic epidermal necrolysis: A propensity-matched retrospective study in China","volume":"12","author":"Yang","year":"2022","journal-title":"Front Pharmacol"},{"issue":"1579349","key":"key20260715102426_b28-BR-25-2-02174","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1579349","article-title":"Plasmapheresis for refractory toxic epidermal necrolysis unresponsive to conventional therapy: A case report and literature review","volume":"16","author":"Liao","year":"2025","journal-title":"Front Immunol"},{"key":"key20260715102426_b29-BR-25-2-02174","doi-asserted-by":"crossref","first-page":"232","DOI":"10.14442\/jgfm.17.3_232","article-title":"Successful combination therapy including plasma exchange for severe toxic epidermal necrolysis","volume":"17","author":"Watari","year":"2016","journal-title":"J Gen Fam Med"},{"key":"key20260715102426_b30-BR-25-2-02174","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/j.1346-8138.2012.01534.x","article-title":"Toxic epidermal necrolysis in a 4-year-old boy successfully treated with plasma exchange in combination with methylprednisolone and i.v. immunoglobulin","volume":"39","author":"Aihara","year":"2012","journal-title":"J Dermatol"},{"key":"key20260715102426_b31-BR-25-2-02174","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s001340051063","article-title":"Lack of significant treatment effect of plasma exchange in the treatment of drug-induced toxic epidermal necrolysis?","volume":"25","author":"Furubacke","year":"1999","journal-title":"Intensive Care Med"},{"key":"key20260715102426_b32-BR-25-2-02174","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1001\/jamadermatol.2023.0035","article-title":"Evaluation of plasmapheresis vs immunoglobulin as first treatment after ineffective systemic corticosteroid therapy for patients with stevens-johnson syndrome and toxic epidermal necrolysis","volume":"159","author":"Miyamoto","year":"2023","journal-title":"JAMA Dermatol"},{"issue":"2893","key":"key20260715102426_b33-BR-25-2-02174","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-53653-5","article-title":"Effectiveness of early treatment with plasma exchange in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Senda","year":"2024","journal-title":"Sci Rep"},{"key":"key20260715102426_b34-BR-25-2-02174","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.12998\/wjcc.v12.i7.1371","article-title":"Double plasma molecular adsorption system for Stevens-Johnson syndrome\/toxic epidermal necrolysis: A case report","volume":"12","author":"Tan","year":"2024","journal-title":"World J Clin Cases"},{"key":"key20260715102426_b35-BR-25-2-02174","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2147\/JIR.S160964","article-title":"A meta-analysis of cyclosporine treatment for Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"11","author":"Ng","year":"2018","journal-title":"J Inflamm Res"},{"key":"key20260715102426_b36-BR-25-2-02174","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jaad.2018.09.063","article-title":"Use of cyclosporine for the treatment of Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"85","author":"Shah","year":"2021","journal-title":"J Am Acad Dermatol"}],"container-title":["Biomedical Reports"],"original-title":[],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T07:24:34Z","timestamp":1784100274000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/br.2026.2174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6,26]]}},"URL":"https:\/\/doi.org\/10.3892\/br.2026.2174","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"value":"2049-9434","type":"print"},{"value":"2049-9442","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]}}}